Selenite induces topoisomerase I and II-DNA complexes in K562 leukemia cells

International Journal of Cancer. Journal International Du Cancer
Miguel López-LázaroCaroline A Austin

Abstract

The essential trace element selenium is one of the most promising cancer chemopreventive agents. Data from preclinical studies have revealed that selenite, an inorganic form of selenium, may also be useful in cancer chemotherapy. DNA topoisomerases (topos) are the target of several useful anticancer drugs. These drugs induce DNA complexes with either topo I or topo II; then cellular processing coverts these topo-DNA complexes into permanent DNA strand breaks that ultimately lead to cell death. Previous reports have revealed that selenite can induce apoptosis in cancer cells selectively and that selenite-induced apoptosis is preceded by the formation of DNA strand breaks. In vitro experiments have shown that selenite induces topo II-DNA complexes, which seem to be involved in selenite-induced apoptosis. Using the cell-based assay TARDIS, here we show that selenite induces topo II-DNA complexes (topo IIalpha and topo IIbeta) in K562 leukemia cells; these complexes appeared in a time-dependent manner and correlated with the induction of apoptosis. Cells lacking topo IIbeta were resistant to selenite-induced cell growth inhibition, suggesting that this isoenzyme is a target for selenite. We report for the first time that selenite i...Continue Reading

References

Jul 17, 1995·Biochemical Pharmacology·J LuH Thompson
Apr 29, 1994·Biochemical Pharmacology·J LuH J Thompson
May 18, 1999·International Journal of Cancer. Journal International Du Cancer·H M ShenC N Ong
Oct 4, 2000·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·P FriskU Lindh
Apr 10, 2002·The Journal of Biological Chemistry·Victor T SolovyanMichael J Courtney
Jun 4, 2002·Nature Reviews. Molecular Cell Biology·James C Wang
May 27, 2003·The Journal of Biological Chemistry·Nai ZhouLeroy F Liu
May 29, 2003·Current Medicinal Chemistry. Anti-cancer Agents·Olivier SordetYves Pommier
Dec 23, 2003·The Journal of Biological Chemistry·Parima DarouiLeroy F Liu
May 20, 2004·Experimental & Molecular Medicine·Yong-sook KimKee-Young Lee
Jun 5, 2004·The Journal of Biological Chemistry·Olivier SordetYves Pommier
Jun 19, 2004·Nutrition and Cancer·Benjamin J WycherlyMerrill J Christensen
Sep 28, 2004·The Journal of Biological Chemistry·Olivier SordetYves Pommier
Jan 20, 2005·Journal of the National Cancer Institute·Scott M LippmanCharles A Coltman
Sep 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Qi ChenMark Levine
Nov 30, 2005·The Proceedings of the Nutrition Society·Margaret P Rayman
Mar 10, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jörg T Hartmann, Hans-Peter Lipp
Aug 29, 2006·Free Radical Biology & Medicine·Gustav NilsonneKatalin Dobra
Aug 29, 2006·Toxicology·Lucia LetavayováJela Brozmanová
Dec 29, 2006·International Journal of Cancer. Journal International Du Cancer·Miguel López-Lázaro
Jan 19, 2007·International Journal of Cancer. Journal International Du Cancer·Guang-Xun LiJunxuan Lü
Apr 7, 2007·Journal of Natural Products·Miguel López-LazaroCaroline A Austin

❮ Previous
Next ❯

Citations

Sep 28, 2010·Archives of Toxicology·Jela BrozmanováMiroslav Chovanec
Jul 17, 2012·Journal of Agricultural and Food Chemistry·Estefanía Burgos-MorónMiguel López-Lázaro
Jan 5, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M T MeloR M Rosa
Feb 15, 2013·Pharmacological Reports : PR·José M Calderón-MontañoMiguel López-Lázaro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis